Dr. Muaiad Kittaneh is a professor of hematology and oncology at Loyola University Medical Center in Illinois. He treats patients diagnosed with mesothelioma, as well as other cancers including breast, gastrointestinal and lung cancer.
Dr. Kittaneh is fluent in Arabic and English, allowing him to serve a diverse patient population. He is also a Spanish speaker, though not fluent in the language.
At Loyola Medicine at Palos Health South Campus, Dr. Kittaneh works alongside more than 40 specialists to holistically treat patients. He, along with his team, treat the patients body as well as their soul.
Main Speciality: Hematology, Oncology
Other Interests & Specialties: Mesothelioma, breast cancer, colorectal cancer, gastrointestinal cancer, lung cancer and stomach cancer.
Certifications, Awards & Accolades: American Board of Internal Medicine Certification in Hematology, American Board of Internal Medicine Subspecialty in Hematology & Oncology
Education & Experience:
- Fellowship for Hematology/Oncology at the University of Miami Hospital and Clinics
- Residency for Internal Medicine at Advocare Christ Medical Center
- Medical Degree from Al-Quds University Medical School, Palenstinian Authority
Detecting germline BAP1 mutations in patients with peritoneal mesothelioma: benefits to patient and family members. Journal of Translational Medicine. July 2018;16(1):194. doi: 10.1186/s12967-018-1559-7
Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG). Breast Cancer Research and Treatment. May 2018;169(1):1-7. doi: 10.1007/s10549-018-4662-9
Safety and pharmacokinetics of veliparib extended-release in patients with advanced solid tumors: a phase I study. Cancer medicine. June 2018;7(6):2360-2369. doi: 10.1002/cam4.1488
- Mesothelioma Doctors
- Cancer Centers
- Treatment Near You
- Experimental Treatments
- Alternative Treatments
- Clinical Trials
- Caregiver Resources
- Treatment Costs